Toxicity of diuron in human cancer cells

Marjo Huovinen1, Jarkko Loikkanen1, Jonne Naarala2

  • 1University of Eastern Finland, Faculty of Health Sciences, School of Pharmacy/Toxicology, Yliopistonranta 1 C, 70210 Kuopio, Finland.

Insights

Diuron herbicide is toxic to human cells, causing DNA damage and reduced cell growth. Its harmful effects may impact fetal development and overall human health, highlighting the need for caution.

Area of Science:

  • Environmental toxicology
  • Cell biology
  • Genotoxicity

Background:

  • Diuron is a widely used herbicide and antifouling agent.
  • Known to be carcinogenic in rats and toxic to various aquatic and terrestrial species.
  • Limited data exists on diuron's genotoxicity in human cells.

Purpose of the Study:

  • To investigate the toxicity and genotoxicity of diuron in human breast (MCF-7) and placental (BeWo) cell lines.
  • To assess the role of reactive oxygen species (ROS) in diuron-induced toxicity.

Main Methods:

  • Exposure of MCF-7 and BeWo cells to varying concentrations of diuron.
  • Measurement of reactive oxygen species (ROS) production.
  • Cell viability and proliferation assays (relative cell number).
  • Comet assay for DNA fragmentation.
  • Western blot analysis for p53 and p21 protein expression.

Main Results:

  • Increased ROS production in both cell lines at high diuron concentrations (200 μM).
  • Diuron reduced viability in BeWo cells but not MCF-7 cells.
  • Inhibited cell proliferation in both cell lines.
  • Increased DNA fragmentation in MCF-7 cells, but not BeWo cells.
  • Upregulated p53 and p21 protein expression in MCF-7 cells.

Conclusions:

  • Diuron exhibits tissue-specific cytotoxicity and potential genotoxicity in human cells.
  • ROS plays a role in diuron's toxic mechanisms.
  • Potential risks to fetal development and human health warrant further investigation.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.2K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
150
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.7K